Диссертация (Возможности фармакологической коррекции когнитивных нарушений у больных артериальной гипертонией), страница 21

выпуск V). — С. 35–44.78. Brands A. M., Biessels G. J., Kappelle L. J., de Haan E. H., de Valk H. W.,Algra A. et al. Cognitive functioning and brain MRI in patients with type 1 andtype 2 diabetes mellitus: a comparative study // Dement. Geriatr. Cogn. Disord.— 2007. — № 23 (5). — С. 343–350.;79. Britton K. A., Gaziano J.

M., Djousse L. Normal systolic blood pressure andrisk of heart failure in US male physicians // Eur J Heart Fail — 2009. — №.11. — С. 1129–1134.80. Butzkueven H., Kolbe S. C., Jolley D. J. et al. Validation of linear cerebralatrophy markers in multiple sclerosis // J. Clin. Neurosci. — 2008. — № 15. —С. 130–137.81. Cacciatore F., Abete P., Ferrara N. et al.

The role of blood pressure in cognitiveimpairment in an elderly population // J. Hypertens. — 2002. — № 15. — С.0135–0142.82. Cervilla J. A., Prince M., Lovestone S. et al. Long-term predictors of cognitiveoutcome in a cohort of older people with hypertension // The british journal ofpsychiatry. — 2000. — № 177. — С. 66–71.83. Danlof B., Devereux R.

B., Kieldsen S. E. et al., LIFE study group.Cardiovascular morbidity and mortality in the Losartan Intervention ForEndpoint reduction in hypertension study (LIFE): a randomised trial againstatenolol // Lancet. — 2002. — № 359. — С. 995–1003.84. Deplanque D., Lavallee P. C., Labreuche J. et al. Cerebral and extracerebralvasoreactivity in symptomatic lacunar stroke patients: a case-control study //Int.

J. Stroke. — 2013. — № 8 (6). — С. 413–421.13785. Dubois B., Albert M. L. Amnestic MCI or prodromal Alzheimer's disease //Lancet Neurology. — 2004. — № 3. — С. 246–248.86. Dufouil C., Chalmers J., Coskun O. Effects of blood pressure lowering oncerebral white matter hyperintensities in patients with stroke: the PROGRESS(Perindopril Protection Against Recurrent Stroke Study) Magnetic ResonanceImaging Substudy // Circulation. —2005. — № 112 (11).

— С. 1644–1650.87. Elias P. K., D'Agostino R. B., Elias M. F., Wolf P. A. Blood pressure,hypertension, к and age as risk factors for poor cognitive performance // Exp.Aging. Res. — 1995. — № 21 (4). — С. 393–417.88. Elias P. K., Elias M. F., Robbins M. A.et al. Blood Pressure-Related CognitiveDecline. Does Age Make a Difference? // Hypertension. — 2004. — № 44. —С. 631.89. Elkins J.

S., Yaffe K., Cauley J. A., Fink H. A. et al. Pre-existing hypertensionand the impact of stroke on cognitive function // Ann. Neurol. — 2005. —№ 58 (1). — С. 68–74.90. Erkinjuntti T., Gauthier S. The Concept of Vascular Cognitive ImpairmentDementia in Clinical Practice // Frontiers in Human Neuroscience.

— 2009. —№ 24. — С. 79–85.91. Farooq M.U., Gorelick P.B. Vascular Cognitive Impairment // Cardiovasculardisease and stroke. — 2013. — № 15. — С. 330.92. Feart C., Samieri C., Barberger–Gateau P. Mediterranean diet and cognitivefunctional in older adults // Curr Opin Clin Nutr Metab Care — 2010. — № 13.— 14–18.93.

Ferri C. P., Prince M., Brayne C., Brodaty H., Fratiglioni L. еt al. Globalprevalence of dementia: a Delphi consensus study // Lancet. — 2005. —№ 366. — С. 2112–2117.94. Fogari R., Mugelllni A., Zoppi A., Derosa G. et al. Influence of losartan andatenolol on memory function In very elderly hypertensive patients // J. Hum.Hypertens. — 2003. — № 17 (11). — С. 781–785.13895.

Fogari R., Mugelllni A., Zoppi A., Lazzari P., Destro M., Rinaldi A., Preti P.Effect of telmisartan/hydrochlorothiazlde vs llsinoprll/hydrochlorothiazidecombination on ambulatory blood pressure and cognitive function in elderlyhypertensive patients // J. Hum. Hypertens. — 2006. — № 20 (3). — С.

177–185.96. Forette F., Seux M. L., Staessen J. A. et al. Prevention of dementia inrandomised double-blind placebo-controlled Systolic Hypertension in Europe(Syst-Eur) trlal // Lancet. — 1998. — № 352. — С. 1347–1351.97. Fukuda H., Kitani M. Differences between treated and untreated hypertensiveP subjects in the extent of periventricular hypertintensities observed on brainMRI // Stroke. — 1995. — № 26 (9).

— С. 1593–1597.98. Geerlings M. I., den Heijer T., Koudstaal P. J. et al. History of depression,depressive symptoms, and medial temporal lobe atrophy and the risk ofAlzheimer disease // Neurology. — 2008. — № 70. — С. 1258–1264.99. Goldstein L. B., Adams R., Becker K. et al. Primary prevention of ischemicstroke: a statement for healthcare professionals from the Stroke Council of theAmerican Heart Association // Stroke. — 2001. — № 32. — С. 280–299.100.

Gorelick P. B., Scuteri A., Black S. E. et al. Vascular contributions to cognitiveimpairment and dementia: a statement for healthcare professionals from theamerican heart association/american stroke association // Stroke. — 2011. —№ 42. — С. 2672–2713.101. Gorelik P. B., Bowler J. V. Advances in vascular cognitive impairment //Stroke. — 2010. — Т. 2. — № 41. — С.

93–98.102. Gottesman R. F., Coresh J., Catellier D. J. et al. Blood pressure and whitematter disease progression in a biethnic cohort: Atherosclerosis Risk inCommunities (ARIC) study // Stroke. — 2010. — № 41 (1). — С. 3–8.103. Grueter B. E., Schulz U. G. Age-related cerebral white matter disease(leukoaraiosis): a review // Postgrad. Med. J. — 2012. — № 88 (1036). — С.79–87.139104. Haan E. H., Nys G. M., van Zandvoort M. J. Cognitive function followingstroke and vascular cognitive impairment // Curr.

Opin. Neurol. — 2006. —Vol. 19 (6). — С. 559–564.105. Hanon O., Haulon S., Lenoir H. et al. Relationship between arterial stiffnessand cognitive function in elderly subjects with complaints of memory loss //Stroke. — 2005. — № 36 (10). — С. 2193–2197.106. Hanon O., Seux M. L., Lenoir H., Latour F., Rigaud A. S., Forette F. Cognitivefunctions and hypertension // Arch. Mai. Coeur. Vaiss. — 2005. — № 98 (2).— С. 133–139.107. Hansson L., Lithell H., Scoog I. et al. Study on Cognition and Prognosis in theElderly (SCOPE) // Blood Pressure. — 1999. — № 8. — С.

177–183.108. Harrington F., Saxby В. K., McKeith I. G. et al. Cognitive performance inhypertensive and normotensive older subjects // Hypertension. — 2000. —№ 36. — С. 1079.109. Helenius J., Tatlisumak T. Treatment of leukoaraiosis: a futuristic view // Curr.Drug Targets. — 2007. — №8 (7) — С. 839–845.110. Henskens L. H., Kroon A.

A., van Oostenbrugge R. J., Gronenschild E. H.,Fuss-Lejeune M. M., Hofman P. A., Lodder J., de Leeuw P. W. Increasedaortic pulse wave velocity is associated with silent cerebral small-vesseldisease in hypertensive patients // Hypertension. — 2008. — № 52. — С.1120–1126.111. Ho M.

S., Weller N. J., Ives F. J. et al. Prevalence of structural central nervoussystem abnormalities in early-onset type 1 diabetes mellitus // J. Pediatr. —2008. — № 153. — С. 385–390.112. Hoffman W. H., Artlett C. M., Zhang W., Kreipke C. W., Passmore G. G.,Rafols J. et al. Receptor for advanced glycation end products and neuronaldeficit in the fatal brain edema of diabetic ketoacidosis // Brain Research.

—2008. — № 1238. — С. 154–162.113. Hoogma R. P., Moll A. C., Snock F. J., Stain C. J., Diamant M. Functionalbrain connectivity and neurocognitive functioning in patients with longstanding140type 1 diabetes with and without microvascular complications // Diabetes. —2009. — № 58. — С. 2335–2343.114. Iadecola C., Park L., Capone C. Threats to the mind: aging, amyloid, andhypertension // Stroke. — 2009. — № 40.

— С. 40–44.115. Jefferson A., Benjamin E. Cardiovascular disease, cognitive decline anddementia / В кн. Vascular cognitive impairment in clinical practice. Под ред.L. Wahlung, T. Erkinjuntti, S. Gauthier. — Cambridge, 2009. — С. 166–177.116. Kalaria R. N., Maestre G. E., Arizaga R. et al. Alzheimer's disease and vasculardementia in developing countries: prevalence, management, and risk factors //Lancet Neurol. — 2008. — № 7 (9). — С. 812–826.117. Kario K., Matsuo T., Kobayashi H., Imiya M., Matsuo M., Shimada K.Nocturnal fall of blood pressure and silent cerebrovascular damage in elderlyhypertensive patients // Hypertension.

— 1996. — № 27. — С. 130–135.118. Kario K., Pickering T. G., Umeda Y. et al. Morning surge in blood pressure asa predictor of silent and clinical cerebrovascular disease in elderlyhypertensives: a prospective study // Circulation. — 2003. — № 107 (10). —С. 1401–1406.119. Kearney-Schwartz A., Rossignol P., Bracard S. et al. Vascular structure andfunctioniscorrelatedtocognitive performanceandwhitematterhyperintensities in older hypertensive patients with subjective memorycomplaints // Stroke.

— 2009. — № 40. — С. 1229–1236.120. Khan U., Porteous L., Hassan A., Markus H. S. Risk factor profile of cerebralsmall vessel disease and its subtypes // J. Neurol. Neurosurg. Psychiatry. —2007. — № 78 (7). — С. 702–706.121. Kilander L., Nyman H., Boberg M., Hansson L., Lithell H. Hypertension isrelated to cognitive impairment: a 20-year follow-up of 999 men //Hypertension. — 1998. — № 31 (3). — С. 780–786.122. Kivipelto M., Helkala E., Laakso M. P. et al.

Midlife vascular risk factors andAlzheimer disease in later life: longitudinal, population-based study // BMG.— 2001. — № 322 (7300). — С. 1447–1451.141123. Kloppenborg R. P., van den Berg E., Kappelle L. J. et al. Diabetes and othervascular risk factors for dementia: which factor matters most? A systematicreview // Eur. J. Pharmacol. — 2008. — № 585 (1). С.